Cross-border capital boosts Midlands as Rem3dy Health raises £1.4m
This article covers Rem3dy Health, a Birmingham-founded healthtech startup, announcing a £1.4m funding round to accelerate its personalised nutrition product Nourished and support international expansion. The round, provided by Amsterdam-based Borski Fund and Future Planet Capital Regional, is intended to fund further R&D, manufacturing and overseas distribution and highlights investor interest in regional, women-led UK startups.
Rem3dy Health, a Midlands-founded healthtech startup, has raised £1.4 million to support international expansion and further development of its personalised nutrition product. The round highlights ongoing investor interest in regional UK innovation and the role of cross-border capital in growing companies outside London.
Why it matters
The funding comes as Birmingham Tech Week and its Scale-Up Summit put a spotlight on the West Midlands as an alternative growth hub to London. Regional founders often face a wider funding gap than their capital-based peers, so a successful raise that supports global ambitions can help change investor perceptions and attract further attention to local ecosystems.
The announcement was made during a panel hosted by The Lifted Project, a Rose Review and Treasury aligned initiative aimed at improving access to investment for high-growth, women-led businesses.
Inside the product
Rem3dy Health develops Nourished, a personalised nutrition brand that uses patented 3D printing technology to produce bespoke, on-demand nutritional solutions. The company says the funding will help accelerate R&D and commercial expansion for the product, which targets preventative, personalised health regimes rather than one-size-fits-all supplementation.
Founder perspective
In the announcement, Melissa Snover, Founder and CEO at Rem3dy Health, said:
This latest round marks a huge milestone not just for Rem3dy Health, but for the Midlands innovation scene. Both Borski and Future Planet Capital share our belief that world-class innovation doesn’t have to start – or stay – in London. This investment proves that regional founders can raise global capital and scale globally from right here in Birmingham.
Snover has previously raised more than £20 million for her ventures, and views the new backing as validation of the company’s global strategy and the Midlands as a base for innovation.
Who’s backing the round
Borski Fund and Future Planet Capital Regional have invested a combined £1.4 million in Rem3dy Health. Borski Fund, based in Amsterdam and known for investing in women-led, high-growth companies, contributed £900,000. Future Planet Capital Regional invested £500,000 and manages the West Midlands Co-Investment Fund.
In the announcement, Jen Roberts-Woods, Investment Associate at Borski Fund, said:
The Borski Fund is proud to back Rem3dy Health, an innovative UK company with worldwide ambitions. Our collaboration with Future Planet Capital highlights the power of international investor partnerships to drive innovation and support exceptional founders. From our first meeting, Melissa’s vision and drive towards realising Rem3dy Health’s global potential was unmissable. The Borski Fund looks forward to working closely with Rem3dy Health as it continues to scale and shape the future of personalised health innovations
In the announcement, Rupert Lyle, [no role specified] at Future Planet Capital Regional, said:
Through the West Midlands Co-Investment Fund, we’re proving that the region can be a launchpad for world-class innovation. Rem3dy Health’s growth story is an outstanding example of what happens when regional founders are backed by both local and global capital: the outcomes are both commercially and socially transformative
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
The bigger picture
The raise arrives amid broader policy and investment activity in the West Midlands, including the launch of the Inclusive Innovation Catalyst, a £30 million venture studio. Initiatives such as The Lifted Project and public co-investment vehicles aim to narrow regional funding gaps, but investors and founders alike point to the need for more consistent follow-on capital and sector-specific support.
For UK and European observers, Rem3dy Health’s round underlines two trends: growing transnational investor interest in regional UK startups, and sustained appetite for personalised healthtech that combines hardware and software innovation. As regional ecosystems mature, securing international partners could become a common route for Midlands founders aiming to scale beyond local markets.
They've invested in Rem3dy Health
Get to know these healthtech investors
Click here for a full list of 7,526+ startup investors in the UK